Core Insights - Altria reported revenue of $5.08 billion for the quarter ended December 2025, showing a year-over-year decline of 0.5% and an EPS of $1.30, slightly up from $1.29 a year ago [1] - The revenue exceeded the Zacks Consensus Estimate of $5 billion, resulting in a surprise of +1.54%, while the EPS fell short of the consensus estimate of $1.32, leading to a surprise of -1.13% [1] Financial Performance Metrics - Revenue from Oral Tobacco Products was $682 million, surpassing the estimated $673.99 million, reflecting a year-over-year increase of +2.9% [4] - Revenue from Smokeable Products was $4.38 billion, exceeding the average estimate of $4.29 billion, but showing a year-over-year decline of -1.1% [4] - Adjusted Operating Companies Income (OCI) for Smokeable Products was reported at $2.64 billion, slightly below the average estimate of $2.67 billion [4] - Reported OCI for Oral Tobacco Products was $438 million, compared to the average estimate of $466.35 million from two analysts [4] Stock Performance - Altria's shares have returned +9.5% over the past month, outperforming the Zacks S&P 500 composite, which saw a change of +0.8% [3] - The stock currently holds a Zacks Rank 3 (Hold), indicating expected performance in line with the broader market in the near term [3]
Compared to Estimates, Altria (MO) Q4 Earnings: A Look at Key Metrics